July 28, 2022
Researchers led by the University of Cincinnati's Agnes (Yu) Luo, PhD, have published findings in the journal Cell Reports showing a novel drug helped to repair the damage caused by ischemic stroke in animal models.
June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
July 1, 2022
The University of Cincinnati's Eva Mistry, MD, is leading the BEST-II study researching how different blood pressure levels following a stroke affect recovery.
July 13, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is leading two research projects to learn more about the relationship between sickle cell disease, stroke and cognitive impairment.
August 2, 2022
The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.
March 7, 2022
Researchers at the University of Cincinnati are expanding the Genetics of Unusual and Familial Movement Disorders study to include genetic testing for Chilean patients in search of a diagnosis for patients with rare movement disorders.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
September 6, 2022
University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.
October 6, 2022
The University of Cincinnati Brain Tumor Center (BTC) held its second-annual Clinical Research Retreat on Sept. 30, bringing researchers from around the country together to discuss advancements in neuro-oncology clinical research.